Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
Vallecillo-Zúniga ML, Rathgeber MF, Poulson PD, Hayes S, Luddington JS, Gill HN, Teynor M, Kartchner BC, Valdoz J, Stowell C, Markham AR, Arthur C, Stowell S, Van Ry PM.
Vallecillo-Zúniga ML, et al. Among authors: van ry pm.
PLoS One. 2020 Sep 3;15(9):e0238441. doi: 10.1371/journal.pone.0238441. eCollection 2020.
PLoS One. 2020.
PMID: 32881965
Free PMC article.